21
DVT and PE Evans Omondi Munyaga Byanjo

Deep Vein thrombosis and Pulmonary embolism

Embed Size (px)

Citation preview

Page 1: Deep Vein thrombosis and Pulmonary embolism

DVT and PE

Evans OmondiMunyaga Byanjo

Page 2: Deep Vein thrombosis and Pulmonary embolism

CONTENT

DefinitionEpidemiologyAetiology Risk factorsPathophysiology Clinical PresentationInvestigationsTreatmentComplicationsPrevention

Page 3: Deep Vein thrombosis and Pulmonary embolism

Defn:

Deep vein thrombosis(DVT)• Is the formation of blood clots in the deep

veins. Most commonly involves calf, femoral or iliac veins.Is less common in the upper limbs but the axillary vein may be involved as a complication of trauma, long venous infusion catheters, neoplasm or radiotherapy.

Page 4: Deep Vein thrombosis and Pulmonary embolism

Epidemiology

• Common in older women >40 years• Incidence is at 0.2% in ante-natal period and

0.6% in postpartum. The incidence rises to 1-2% post caesarian section.

• Left leg>80%• Ileofemoral more common than calf vein (72%

versus 9%)• Unfortunately only 5-10% are symptomatic.

Page 5: Deep Vein thrombosis and Pulmonary embolism

Aetiology

This is based on the Virchow’s triad: • Stasis• Endothelial injury• Hypercoagulability stateVenous stasis-immobility (prolonged bed rest, limb paralysis) low cardiac output(heart failure) varicose veins.

Page 6: Deep Vein thrombosis and Pulmonary embolism

• Venous injury- Trauma, i.v cannulation.• Increase coagulability-malignant diseases,

drugs(oestrgen,oral contraceptives)dehydration,polycythaemia

• Inherited coagullation effect- Antithrombin III, protein C, protein S.

Page 7: Deep Vein thrombosis and Pulmonary embolism

Risk factors

• Abdominal or pelvic surgery• Old age• Prolonged surgery and general anaesthesia• Obesity• Malignancy• Prior DVT• Increase coagulation diseases-protein C or S

Page 8: Deep Vein thrombosis and Pulmonary embolism

• Oestrogen• Oral contraceptive pills• Smocking• Prolonged bed rest• Pregnancy

Page 9: Deep Vein thrombosis and Pulmonary embolism

Pathophysiology

• The thrombus occur in the deep veins of the leg. Usually originate around the valves. The calf vein is the usual site.

• It may also originate in the iliac or femoral vein.

• There is progressive obstruction following thrombosis in the deep veins.

Page 10: Deep Vein thrombosis and Pulmonary embolism
Page 11: Deep Vein thrombosis and Pulmonary embolism

Clinical presentation

Symptoms:»Asymptomatic »Pain» Swelling » Increase in temperature» Engorgement of superficial veins» Erythema

Page 12: Deep Vein thrombosis and Pulmonary embolism

Signs:» Fever, calf warmth, tenderness, pitting

oedema, cyanotic limb.» Homan’s sign (increased resistance/ pain on

forced foot dorsiflexion)- may dislodge the thrombus.

Page 13: Deep Vein thrombosis and Pulmonary embolism

Well’s Score

Each of following scores a point» Active cancer(Rx within last 6mths or palliative)» Paralysis, paresis or recent plaster immobilisation» Major surgery in last 4wks or recently bedridden > 3days.» Local tenderness along distribution of deep venous system» Entire leg swollen» Calf swelling > 3cm compared to asymptomatic leg measured 10cm below the tibial tuberosity» Pitting oedema> in the symptomatic leg» Collateral superficial vein

Page 14: Deep Vein thrombosis and Pulmonary embolism

» Alternative diagnosis is more likely than DVT minus 2 pts.

» Score ≥ 3pts, DVT is likely» Score 1-2, treat as suspected DVT and perform

compression US» Score ≤ 0 perform D- dimer test.

Page 15: Deep Vein thrombosis and Pulmonary embolism

Investigations

• Ascending venograpthy; invasive but more sensitive than duplex

• Doppler U/S• Blood • CBC• INR• Duplex U/S• Venography

Page 16: Deep Vein thrombosis and Pulmonary embolism

Treatment

• Aim of Rx is to prevent further thrombosis and pulmonary embolisation,

• Bed rest, elevate the limb, good hydration.• Calf vein thrombosis may be treated by

compression stockings. • LMWH e.g. Enoxaparin preferred to

unfractionated heparin because:» It has a higher bioavailability.» Less risk of bleeding

Page 17: Deep Vein thrombosis and Pulmonary embolism

Oral anticoagulants:» Warfarin- it inhibits synthesis of vitamin k dependent

clotting factors (II, VII, IX, X), proteins C and S.» LMWH is given first for 3-5 days then Warfarin» The duration for Warfarin is still debatable

However if the risk is reversible its given for 6wks-6months

» Before starting and during treatment, the patient’s INR is monitored.

Page 18: Deep Vein thrombosis and Pulmonary embolism

DDx

• Ruptured Baker’s cyst• Cellulitis• Calf hematoma• Lymphoedema

Page 19: Deep Vein thrombosis and Pulmonary embolism

Complication

• PE-most feared• Venous Gangrene• Recurrent DVT• Varicose veins• Chronic venous insufficiency• Post phlebitic syndrome (pain, oedema,

ulceration)

Page 20: Deep Vein thrombosis and Pulmonary embolism

Prevention

• Avoid the risk factors-obesity,smoking• Prevent blood stasis in susceptible patients

through ambulation, use of elastic stockings, exercise or elevation of legs

• Prophylaxis of susceptible patients with low dose Aspirin

Page 21: Deep Vein thrombosis and Pulmonary embolism

Thank you